Management is buying/committing capital at a price it says the market itself just set against it — cheapness measured ag
The model's full reasoning — Q4 2023 call → NOThe question asks whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. Let me analyze the transcript carefully. Key elements needed: 1. A mispricing claim anchored to something concrete 2. The company acting on it with real resources, already in motion Let me search through the transcript for any discussion of buybacks, share repurchases, or the company's stock being undervalued. Looking through the transcript: - Marc Grandisson discusses the company's performance, underwriting, growth in various segments - François Morin discusses financial results, capital position, Bermuda corporate income tax - There's discussion of M&A approach - Discussion of casualty market, reinsurance market, mortgage insurance - Discussion of capital deployment and growth opportunities I don't see any discussion of: - The company's stock being undervalued - Share buybacks or repurchases - The company acquiring its own shares - Any claim that the market is mispricing the company's assets - Any concrete benchmark showing the company is worth more than the market values it The discussion is about underwriting opportunities, market conditions, growth in insurance and reinsurance segments, capital deployment into the business. There's no mention of the company's own shares being cheap or the company buying back stock. The closest topics are: - M&A approach (but that's about acquiring other companies, not about the company's own mispricing) - Capital deployment into growth opportunities (but that's routine capital allocation, not about mispricing of the company's own assets) There's no discussion of the company's stock price being low relative to book value or any intrinsic value. No mention of buybacks. No mention of the company retaining exposure because outsiders are mispricing it. The answer is clearly NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CTHR | Charles & Colvard, Ltd. | Q1 2023 | 2022-11-06 | F |
| SBGI | Sinclair Broadcast Group, Inc. | Q3 2022 | 2022-11-02 | C |
| WD | Walker & Dunlop, Inc. | Q2 2022 | 2022-08-09 | C+ |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
TWO · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the mispricing to concrete, verifiable levels: mortgage spreads at “historically wide” levels (125–150 bp ZV/OAS, far above the non-QE average and the March 31 levels), RMBS coupons now trading at a wide range (2 %–5.5 %) with 300 bp “out-of-the-money” low-coupon pools and 97 bp OAS–ZV spread differential on higher-coupon names.
ESEA · Q4 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete, verifiable figure: their own estimate of the fleet’s market value at $666 million (derived from charter-adjusted values and market changes, incorporating the Aegean Express incident), which produces a net asset value of $344 million or >$48 per share.
WD · Q2 2022 → YESThe question is whether management describes the company deliberately taking on more of its own economic exposure because it believes the outside world is currently mispricing what it already has. YES Management anchors the undervaluation claim to a concrete benchmark: CoStar trades at ~30x EBITDA while W&D trades at under 10x despite identical revenue and EBITDA growth rates over 5–10 years. They explicitly state there is “plenty of multiple expansion available to W&D.